2024 PRIMO | Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer

2024 PRIMO | Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

William J. Gradishar, MD, FASCO, FACP

Date of Release

May 14th, 2025